Mental disorders in primary care by Wittchen, Hans-Ulrich et al.
n most health care systems, primary care doc-
tors are the cornerstone of recognition,diagnosis,treat-
ment, and specialist referral for all types of disorders,
whether they are somatic, psychological, or both.The
past two decades have witnessed a further emphasis of
this role, particularly with regard to the treatment of
mental disorders in primary care. Several reasons
account for this. First, mental disorders are extremely
prevalent in the community,and much more than previ-
ously thought.Current epidemiological findings suggest
that almost 50% of the population will experience at
least one mental disorder in their lifetime, and at least
25% have suffered from a mental disorder during the
past 12 months.
1-3 Second,international epidemiological
evidence suggests that,of all the people with mental dis-
order who receive treatment, a large proportion obtain
at least minimal intervention through their primary care
doctor.
4,5Third,the continuing trend of reducing psychi-
atric hospital beds contributes to a larger burden of psy-
chiatric patients in outpatient and,particularly,primary
care settings. Finally, the rapidly accumulating knowl-
edge in clinical neuroscience and clinical psychology has
resulted in various new treatment options for a wide
range of neuropsychiatric conditions and disorders,and
many of these can be applied in primary care.
In most systems, the majority of people report at least
one primary care visit per year, thereby maintaining a
stable and enduring relationship.On this basis,the gen-
eral practitioner (GP) may develop a deeper under-
standing of individual vulnerability for certain diseases,
illness behavior,the waxing and waning of disorders,the
development of somatic and mental comorbidities, and
the ability to overcome the direct and indirect effects of
diseases. GPs also frequently have a more intimate
knowledge of the psychosocial context in which patients’
distress and illnesses occur (ie,interpersonal and family
crises, occupational and employment problems, and
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I
Current estimates indicate that 50% of the population
experience at least one mental disorder in their lifetime
and that at least 25% have suffered a mental disorder in
the past year. Recognition, diagnosis, treatment, and
referral depend overwhelmingly on general practitioners,
at least one third of whose consultations have a direct and
explicit psychological component. Yet despite this inten-
sive familiarization with the presentation of mental
pathology, and the appropriateness of the primary care
setting to its management, even the most recent surveys
indicate that performance is best described by the rule of
diminishing halves: only half the patients with a thresh-
old disorder are recognized; only half of those recognized
are treated; and only half of those treated are effectively
treated. There is no single solution to this problem, only
multiple solutions, which must be aimed, consistently and
simultaneously, at the patient, practitioner, practice, and
research levels. Dialogues Clin Neurosci. 2003;5:115-128.social,environmental,and financial difficulties).Finally,
a visit to a GP even for mental health reasons does not
carry the same amount of stigma as a visit to a mental
health specialist.Thus, the barriers to help-seeking and
acceptance of treatment are considerably reduced in pri-
mary care.
Mental disorders in primary care: 
poorly studied and poorly understood
In light of this situation,it is paradoxical that mental dis-
orders in primary care—and the way they are man-
aged—remain poorly studied.With a few notable excep-
tions (see below),this statement applies to both the size
of the problem (ie, frequency and type of mental disor-
ders seen in primary care) and the more complex set of
questions regarding the quality of care (accuracy of
recognition, diagnosis, and management). Thus, the
extent to which these functions are fulfilled in primary
care remains largely unclear.Another question concerns
the domains of mental disorders and specific treatments
in which primary care providers are at a disadvantage in
terms of qualifications and provision of state-of-the-art
therapy.
This lack of data is particularly evident from a broader
international perspective.Despite the considerable body
of published results on some of these issues,the findings
are mostly confined to certain disorders and to selected
areas and countries (UK and USA).Thus, they cannot
be generalized to the ensemble of countries,health care
systems, and disorders. Between countries, especially
within Europe,there are tremendous differences in the
way primary care services operate.For example,in some
countries (eg, USA or Germany), patients have direct
access to mental health specialists, whereas in others
they require prior referral by a GP.
As part of the International Consortium of Psychiatric
Epidemiology (ICPE) program,Bijl et al
5 recently high-
lighted some of these differences in a five-country com-
parison to examine the proportion of people with men-
tal disorders who received treatment in the past 12
months.Ascertained treatment rates varied from a low
of 7% in Canada to a high of 17.3% in Chile, with the
US rate being 10.9%. Respondents were also asked
about the sector of treatment,distinguishing the general
medical sector (eg,GP),the specialty sector (psychiatrist
or psychologist), and other human services (self-help
groups, social services, counseling centers, etc).The dis-
tribution by sector varied significantly across countries.
The countries in which the majority of patients were
seen in the general medical sector were Chile (80.3%),
the Netherlands (74.6%), and Canada (65.7%), com-
pared with the USA (43%) and Germany (36.6%).
Tremendous national differences are also found with
regard to GPs’ workload.Whereas Scandinavian doctors
rarely see more than 20 patients a day,German doctors
usually have 70 or more daily patient contacts. Clearly,
it is hard to see how quality measures in a country with
20 patients a day can be compared with countries with
up to 100 patients.
With these caveats in mind, this paper will review the
patchwork of available findings for mental disorders in
an attempt to identify past research achievements and
deficits in currently available data.After a few remarks
on general diagnostic problems,this review will focus on
the most prevalent mental disorders (depression, anxi-
ety, and eating and substance disorders) for which at
least one major study is available.
Symptoms and diagnosis of mental disorders
The expression of mental health problems, emotional
distress,and even clear-cut mental disorders vary widely
in terms of presenting problems, severity, complexity,
associated impairment,duration,and risks.In most cases,
it is not possible to simply equate a diagnosis with a
need for immediate intervention.The GP may face even
greater problems regarding the relationship between
specific disorders and the indication of specific treat-
ments, due to the high degree of comorbidity typically
found for mental disorders.
6
As evidenced by an international WHO study,
7 about
one third of GP consultations have a direct and explicit
psychological component,in terms of full-blown depres-
sive syndrome,anxiety,or somatoform disorder (Figure
1A).
8,9 European GPs estimate that more than 30% of
their patients have a clinically relevant mental disorder,
at least to a moderate degree.However,this proportion
may be considerably higher if subthreshold conditions
or clinically significant psychological problems are con-
sidered, adding an additional 30%. Such high numbers
are also found when a standardized diagnostic interview
is applied.Figure 1B shows that,according to Diagnostic
and Statistical Manual of Mental Disorders,Third Edition
Revised (DSM-III-R)
10 criteria, the total prevalence of
any threshold disorder is 25% to 28%. If subthreshold
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diagnosis, are considered, another 8% to 9% can be
added.
This high frequency of clinically significant mental
health syndromes (with a total prevalence of over 50%)
raises the question of what constitutes a case requiring
professional treatment in primary care. For a better
understanding of recognition and treatment issues in
primary care,it is essential to consider first the patients’
presenting complaints and subjective suffering (illness),
and then the usual progression from these to the estab-
lishment of a diagnosis (disease) of a specific mental dis-
order and to treatment decisions in medical settings.
To illustrate,when patients complain of persistent sleep
problems,they may receive,according to their doctor’s
diagnostic workup, the diagnosis of a sleep disorder
(insomnia) and a prescription for hypnotics.Alternatively,
their doctor may notice that the sleep problems have
occurred together with a wide range of persistent depres-
sive symptoms over the past 3 weeks,which justifies the
diagnosis of major depression (MD), prompting some
counseling and a prescription for antidepressants or even
referral for psychotherapy.Some,but not all,of the con-
siderable problems involved in the definition and diag-
nostic classification of physical illnesses may be aggra-
vated in mental illness and disorders.Sleep complaints
could be a sign of a disorder like insomnia or depression,
but exactly the same symptoms could also be present in
transient unhappiness or distress.Thus, the borderline
between symptoms due to unhappiness or distress,on the
one hand,and symptoms due to threshold mental disor-
ders,on the other,is often indistinguishable.
This problem seems to be aggravated by shifts of para-
digms in diagnostic classification for mental disorders.In
contrast with previous scientifically unproven nosologi-
cal classifications of mental disorders,which were of poor
reliability and validity,the current versions of Diagnostic
and Statistical Manual of Mental Disorders,Fourth Edition
(DSM-IV)
11 and International Statistical Classification of
Diseases, 10th Revision (ICD-10)
9 have now adopted a
largely descriptive approach with operationalized criteria
for disorders.This shift in paradigm has resulted in a con-
tinually increasing number of diagnostic classes from 59
disorders early in the 20th century to 347 major classes in
DSM-IV.
11 Does this increasing sophistication truly reflect
scientific progress (driven by valid data) or is it simply an
epidemic of artificial medicalization? Moreover,is it help-
ful for sufferers and GPs,or only for specialists? Health
care professionals in general,and GPs in particular,must
constantly reexamine at what point it becomes helpful to
the patient to classify their mental distress as mental ill-
ness
12 because this decision also implies the danger of
stigmatization or suboptimal treatment allocation.
Despite the undisputable progress and the consequent
increased reliability and validity of psychiatric diagnoses,
these problems remain unresolved and have given rise to
questionable heuristics aimed at simplifying heterogene-
ity (ie,serious versus nonserious,or minor versus major
mental disorder).
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Figure 1. General practitioner (GP)–rated mental health status (A) and
diagnostic status according to Composite International
Diagnostic Interview (CIDI) (B) in unselected primary care atten-
dees in Germany and the European Union (EU). 
Modified from reference 8. Linden M, Maier W, Achberger M, et al. Psychische
Erkrankungen und ihre Behandlung in Allgemeinarztpraxen in Deutschland.
Ergebnisse aus einer Studie der Weltgesundheitsorganization (WHO). Nervenarzt.
1996;67:205-215.
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mental disorders in primary care
Before presenting some more recent findings on selected
disorders,it should be noted that only one major inter-
national study has directly addressed the question of
prevalence,recognition,and treatment of a wide range of
mental disorders in primary care.This benchmark study
is the WHO study Psychological Disorders in Primary
Care,and was conducted in 18 countries in the eighties.
7
Although only a small proportion of mental disorders
were covered, the total point prevalence of threshold
ICD-10 diagnoses across centers was 24%, with some
variation between countries (from 20% in Shanghai to
50% in Santiago de Chile). Major depressive disorders
(10%) and generalized anxiety disorders (GADs, 8%)
were the most frequent diagnoses, followed by neuras-
thenia (5%), alcohol dependence (3%), and somatiza-
tion disorder (3%) (Table I). This study focused on
threshold cross-sectional diagnoses and excluded par-
tially remitted or subthreshold disorders; the estimates
can thus be regarded as conservative.
In terms of recognition and treatment,the study revealed
that GPs recognized only 49% of the mental disorders
ascertained by the study instrument. Moreover, only
about half of all cases recognized received some specific
intervention,and the majority of these treatments were
not considered to be state-of-the-art first-line treatments.
Another puzzling result was that,in addition to the 25%
rate of threshold disorders,the treating physicians also
labeled an additional 11% of patients as having a mental
disorder that was not ascertained by the study instrument.
It remains unclear whether a proportion of these patients
were incorrectly diagnosed, or whether these findings
reflect partially remitted mental disorders or an episode
that did not yet meet current research criteria,or indeed
whether the patients or diagnoses were not completely
covered by the research study.
The study also highlighted a tremendous variation
between centers and between diagnoses in terms of
prevalence, recognition, and treatment.This variation
may indicate considerable differences in provider mod-
els of primary care around the world, cultural distinc-
tions, and the fact that well-defined disorders (like
depression) are better recognized, diagnosed, and
treated than rarer and ill-defined conditions.
13
Depressive disorders
Studies in the 1980s and early 1990s conducted in pri-
mary care in various countries with fairly convergent
methods and designs
14 confirmed that depression is
indeed a quite frequent problem in primary care.The
point prevalence for depressive disorders has been esti-
mated with some variation to be about 10% of all pri-
mary care attendees.
7,15-19There is also fairly consistent
agreement that, among patients with clinically signifi-
cant depression, over 50% were not recognized by the
treating primary care physician.
7,20-22 Moreover, among
those recognized,only a fraction appear to receive treat-
ments that could be described as adequate according to
expert guidelines.
18,22-27 Remarkably,these findings apply
even to most recent studies, even after many years of
action to improve GPs’ ability to recognize the presence
of depressive disorder in patients.
19
Out of all the mental disorders,depression has certainly
received the greatest attention,in terms of both indirect
evidence from community studies and direct evidence
by investigations in primary care settings. A compre-
hensive community survey,the ICPE (which reanalyzed
data from the general population in 6 countries
2),
recently examined the general population who had suf-
fered a depressive disorder in the past 12 months: only
about a fifth in Canada (22%) and the USA (22%),and
slightly more in the Netherlands (32%) and Germany
(29%),actually received any type of treatment.The key
role of primary care was strongly confirmed in this study,
in that the vast majority of patients in all countries were
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Table I. Prevalence of current International Statistical Classification of
Diseases, 10th Revision (ICD-10)
9 disorders
7 according to the
Composite International Diagnostic Interview (CIDI).
Disorder Prevalence (%)
Current depression 10.4
Generalized anxiety disorder 7.9
Neurasthenia 5.4
Harmful use of alcohol 3.3
Alcohol dependence 2.7
Somatization disorder 2.7
Dysthymia 2.1
Panic disorder 1.1
Agoraphobia with panic 1.0
Hypochondriasis 0.8
Agoraphobia without panic 0.5
Any CIDI disorder 24.0
Two or more mental disorders 9.5cared for exclusively in the primary health care sector.
Few received treatment from mental health specialists.
It is noteworthy that intervention or treatment in this
analysis was merely defined as any treatment contact,
irrespective of appropriateness in terms of type, dose,
and duration of treatment.A further disturbing finding
from community studies is that, for the majority of
patients,it takes many years from the first onset of their
disorder to the prescription of appropriate treatment.
28
The recent German study,Depression 2000,was based
on a national representative sample of 412 GPs and had
a three-stage design
29 in 15 081 consecutive primary care
attendees.This study revealed that of the 11% of patients
meeting diagnostic criteria for DSM-IV episode of MD
in this study,two-thirds were recognized by the primary
care practitioner as having a clinically severe mental
health problem,but only 39% were correctly diagnosed
as definitely having depression,and an additional 16%
as having a probable depression.Recognition rates were
especially poor in males (correct identification rate 27%)
and females (33.2%) aged less than 40 years.
30
If the treatments chosen worked equally well in all types
of mental disorders,then the poor recognition of depres-
sion would not be an important issue.However,it is note-
worthy that the unsatisfactory recognition pattern and
the diagnostic imprecision had remarkable effects on the
doctors’ subsequent intervention behavior: more than
40% of all patients meeting DSM-IV criteria for MD did
not receive any treatment or significant intervention of
any kind! MD cases correctly recognized as at least
“probable depression”by the GP had the greatest likeli-
hood (65%) of receiving first-line antidepressants (37%),
psychotherapy (9%),or being referred to a mental health
specialist (22%). Despite no significant differences in
symptomatology,MD cases recognized as simply “hav-
ing a mental health problem”without a specific depres-
sion diagnosis received first-line treatments considerably
less frequently (42%),whereas cases without any rating
as a clinically significant problem went largely untreated.
They were also more likely to be treated with a sedative
or hypnotic,but less likely to receive a neuroleptic or a
herbal medication. With regard to the type of antide-
pressant prescribed, modern antidepressants, such as
noradrenergic and specific serotonergic antidepressants
or selective serotonin reuptake inhibitors (SSRIs),were
more likely to be prescribed for patients diagnosed with
depression than tricyclic antidepressants.These findings
were by and large confirmed in a more recent primary
care study using the identical design in Scandinavia
31
(Munk-Jurgensen,personal communication).
In accordance with previous research, the Depression
2000 study
29 showed that the correct recognition of
depression and the likelihood of receiving adequate
treatment were associated with a similar set of predic-
tors on the patient’s side: older age, prior depression or
treatment history, depressed mood as the primary rea-
son for consulting the doctor, and suicidal ideation.
Current severity also had an effect (odds ratio [OR] 1.2),
although not as great as that associated with the other
factors.On the doctor’s side,surprisingly few predictors
were identified: doctors who had attended a high num-
ber of courses on depression in the previous 2 years had
a greater probability of correctly recognizing a patient
with depression (OR 2.1); doctors with >20 years of
experience (ie, the older doctors in the sample) had a
considerable lower recognition rate (OR 0.5). Taking
their attitudes toward depression into account and their
theoretical background,the authors speculate that older
doctors tend to rely heavily on the traditional nosolog-
ical classification systems, which differentiate between
endogenous versus neurotic and reactive depression.
This subgroup of older—and seemingly more experi-
enced—doctors were particularly poor at recognizing
depression in young people.
The study
29,30 concluded that,despite numerous attempts
to improve doctors’ recognition rates and prescription of
appropriate treatment,only modest improvements have
been made.Moreover,although GPs manage the typical
severe,melancholic patient relatively well,marked deficits
were evident for young patients, new cases of incident
depression,and cases with comorbidity with other men-
tal disorders.The major barriers for improved recognition
and treatment in this study were the time burden of the
treating physician and failure to adopt the current
descriptive way of diagnosing depression,as opposed to
the traditional nosological approach.
Anxiety disorders
In contrast with the large number of studies in depression,
anxiety disorders remain a relatively neglected topic of
systematic primary care research.This is surprising con-
sidering (i) that about a quarter of the general population
is or has been affected at some point in their lives by an
anxiety disorder;(ii) the chronic nature of anxiety disor-
ders;(iii) the early onset of most forms of anxiety disor-
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119ders;and (iv) the high probability that primary anxiety
might be a powerful risk factor for secondary depression
and substance abuse. Further, there is substantial evi-
dence
32 that psychoeducative efforts and brief interven-
tions might be very effective in uncomplicated cases and
in the early stages of anxiety disorders,even if applied in
primary care.Obviously,the misconception of anxiety dis-
orders as belonging to the less severe morbidity spectrum,
with no explicit need for immediate intervention,is the
cause of this neglect.
The available evidence is largely limited to two anxiety
disorders: panic disorder (PD) and GAD, which are
assumed to be the most severe and chronic forms.The
available evidence generally suggests a somewhat worse
picture than for depression.Of all anxiety disorders,less
than 50% are recognized and even fewer are specifically
diagnosed.
Panic disorder
According to Spitzer et al,
33 PDs occur in about 4% of
patients in US primary care,although other studies sug-
gest that this is an upper-bound estimate (ie, the true
value might be lower).
7 PD is frequently associated with
agoraphobia and differs from most phobic disorders in
terms of acute severity,extensive use of medical services,
high costs, multiple unexplained medical illnesses and
therefore increased rates of laboratory testing, and as
much impairment and disability as other severe medical
illnesses. Similar to depression, <50% of cases are rec-
ognized and few receive adequate diagnosis or treat-
ment in the form of antidepressant drugs, cognitive
behavior treatment,or referral to specialists.
33
Katon et al
34 were unable to show that educational cam-
paigns and treatment guidelines have any sustained and
significant effect on improved recognition.However,they
recently demonstrated
34 that collaborative care inter-
ventions in US primary care,consisting of follow-up with
the psychiatrist who made the initial SSRI prescription
and psychoeducation,can result in remarkable improve-
ments in terms of symptom reduction.Although direct
treatment costs were substantially higher with this
approach,the overall costs due to reduction in indirect
costs were superior to usual treatment.It is difficult to
generalize these findings to other regions and countries,
but it nevertheless ranks among the few promising alter-
native approaches to be pursued in the future for this and
other disorders.
Generalized anxiety disorder
GAD is a severe and chronic anxiety disorder,for which
effective drug and psychological treatments have
recently become available.The lifetime prevalence of
GAD in the general population has been estimated to
be 5% to 6%,
31,35,36 which is more than PD.GAD patients
are also frequently described as high health care users,
particularly of primary care resources. GAD is a highly
disabling condition that results in significant impair-
ments in terms of work productivity, performance of
everyday activities,quality of life,and well-being.
37,38This
can be equivalent to, or even greater than, those asso-
ciated with other chronic physical or mental disorders.
39
While chronic worrying and the physical effects of
chronic tension are the principal features of GAD,
patients with this condition primarily present to their GP
with somatic, pain, or sleeping complaints, rather than
anxiety or worry.
40 This well-known phenomenon of
somatization has also been found in many cases with
depression and has been held responsible for low recog-
nition of mental disorders in primary care.
30,41 The most
commonly occurring somatic complaints are insomnia,
chest pain,and abdominal pain,
13 and patients frequently
undergo extensive and costly diagnostic procedures to
rule out physical conditions.
42 During these investiga-
tions,patients often do not receive the treatment that is
appropriate for their psychiatric disorder,and may never
do so.In addition,an undue financial burden is imposed
upon the health services.Another critical issue is the fre-
quent comorbidity with depression,other anxiety disor-
ders,and chronic physical conditions,which complicates
the clinical presentation,makes diagnosis more difficult,
increases the degree of impairment,
43 and worsens the
patient’s prognosis.In light of the various effective treat-
ment options for GAD that have recently become avail-
able, it is important that GAD is diagnosed as early as
possible to minimize the potential for the subsequent
onset of depression,while improving the patient’s qual-
ity of life and prognosis,and reducing health care costs.
The high point prevalence of 8% of all primary care
attendees,
7 rendering GAD second only to depression
as the most common disorder in primary care,
44,45 has
made improved recognition and earlier treatment a high
priority in recent primary care research (Ballenger et al,
personal communication).
In probably the largest primary care study on this issue,
the Generalized Anxiety and Depression in Primary Care
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(GAD-P) study
46 recently confirmed the high prevalence
of GAD even in its pure form (uncomplicated by depres-
sion) and showed that GAD patients are high users of pri-
mary care resources.
31 For example,it has been reported
that gastroenterologists are the specialists seen most often
by GAD patients (23%).
47This contrasts with other disor-
ders such as social anxiety for which the point prevalence
is lower in primary care than in the general population.
48
In remarkable contrast,the GAD-P study revealed that
patients with GAD are a great challenge to GPs, as
demonstrated by extremely poor recognition and treat-
ment rates.Despite the fact that GPs acknowledged the
severity of their GAD patients by assigning some mental
disorder in 73% of the patients, only a third were diag-
nosed correctly and only 10% overall received the current
state-of-the-art treatment.
31The predictors for correct diag-
nosis were similar to those identified for depression;how-
ever, poor knowledge about the fact that this diagnosis
exists and that specific treatments for this disorder are
available played a much greater role than for depression.
Eating disorders
The prevalence of eating disorders in the total popula-
tion is low,with lifetime estimates of around 1% to 2%;
however,the rates among adolescents and young adults
are considerably higher (two- to threefold).Despite the
low prevalence, the considerable health-related short-
and long-term consequences and the substantial risk for
comorbidity and premature mortality make the GP an
important route to specialist care.
49 The evidence for
increasing rates of bulimia nervosa
50 adds further to this
need and requires greater attention in the future.
Few systematic studies are available to describe the fre-
quency, recognition, and specific forms of intervention
applied in eating disorders in primary care.On the basis of
primary care registries with administrative diagnoses for
the UK, Schmidt
49 estimated that the average GP has
about 2 patients with anorexia nervosa and about 18
patients with bulimia nervosa on their list of registered
patients.Despite the fact that eating-disordered patients
consult their GPs more frequently than control subjects,
51
GPs were unaware of the diagnosis in up to 50% of cases
discovered by research interview.
52,53These patients pre-
sented to their GP with a variety of symptoms,including
psychological, gastrointestinal, and gynecological com-
plaints.In many cases,the earlier consultations to the GP
had been prompted by complications of the eating disor-
ders, but the diagnosis was missed. Many reasons have
been evoked to account for these problems,including the
patients’ tendency to hide the problem verbally as well as
by wearing baggy clothes,social factors (lower socioeco-
nomic status,ethnic minority),and gender (males are not
expected to have eating disorders).Some indications were
also found for specific communication barriers: female
patients do not expect their mostly male doctors to under-
stand their problem or to be sympathetic about it.A sur-
vey by the Eating Disorder Association (cited in reference
50) revealed that 43% of 1638 respondents with eating dis-
orders found that their initial consultation with the GP was
unhelpful.Other important barriers specifically relate to
the problem of the compulsory treatment of severe
anorexia nervosa.The few systematic primary care studies
available do not lead to any conclusions about how to
improve recognition or treatment rates,which seem to be
at least as deficient as those for anxiety and depression.
There is some evidence that at least early recognition and
short motivational interviewing techniques for subsequent
specialist treatment are high-priority topics for improved
primary care in this subgroup of disorders.
Substance abuse disorders
Although there are a considerable number of studies
that have highlighted the beneficial effects of improved
recognition of alcohol and nicotine disorders by GPs, it
should be noted that systematic epidemiological primary
care results on prevalence,recognition,and treatment of
these conditions are only slowly becoming available.
Taking the prevalence obtained from studies in the com-
munity,we can estimate that at least a fifth of all primary
care patients have some type of substance disorder,most
frequently nicotine or alcohol dependence.Although it
is hard to conceive how GPs could provide state-of-the-
art specialist substance abuse treatment in these patient
groups, which are notorious for being particularly chal-
lenging,screening,recognition,referral,and motivational
enhancement techniques are usually seen as a standard
requirement in primary care.
Theoretically,GPs are in a unique position to at least inter-
vene in legal substance abuse problems.They avoid the
stigma attached to specialist addiction units and have the
advantage of comprehensively overlooking the long-term
development and somatic and mental risks. In light of
these advantages,numerous short brief intervention pack-
ages and programs have been launched and considerableeffectiveness has been demonstrated in controlled trials.
The focus of most of these programs (for example, the
United Kingdom Alcohol Treatment Trial [UKATT],the
National Treatment Outcome Research Study [NTORS],
and the Smoking and Nicotine Awareness and Treatment
Study [SNICAS]) is mostly on motivational techniques
(such as motivational enhancement therapy [MET]) for
nicotine and alcohol abusers,as well as behavioral treat-
ments sometimes supplemented by drugs.
The outcomes of such endeavors are frequently disap-
pointing.The recent SNICAS trial
54 in Germany revealed
that 16% of consecutive male and 12% of female primary
care attendees have a current nicotine dependence (Figure
2).Although they were aware of the aim of the study,the
GP recognized only 76% of these patients as smokers,dis-
cussed the need for stopping with only 23%,and actually
made an attempt to provide help in only 13%.
A further disappointing finding refers to patients’ lack
of motivation to stop immediately and register for a sys-
tematic state-of-the-art smoking cessation program and
GPs’ apparent inability to perform appropriate motiva-
tional techniques.Thus,<1% of smokers actually receive
some intervention.These findings clearly indicate that
substance abuse treatment in primary care remains far
from being a realistic option in routine care.
Discussion
The importance of the problem in mental disorders
Clinical epidemiological studies are providing an
increasingly sharper and fairly convergent picture about
the importance of mental disorders in society,as well as
in primary care. Community studies indicate that men-
tal disorders affect at least 50% of the general popula-
tion at least once in their lifetime,and generally indicate
that about 20% of the population is acutely affected by
at least one mental disorder at any point in time. In
accord with these prevalence estimates,it is not surpris-
ing that the point prevalence among unselected primary
care attendees is even higher.Since there are no studies
in the literature that have estimated and described a
fuller range of all existing mental disorders and their
patterns of comorbidity, it is impossible to state at this
point what proportion of patients in primary care are
suffering from at least one mental disorder. It should
also be noted that estimates based on administrative
records (case registries) are not informative due to the
marked deficiencies of GPs in assigning appropriate and
sensitive diagnoses.
Almost all the studies examined one or few selected
groups of disorders, most frequently depressive disor-
ders, some types of anxiety disorders, and considerably
less frequently somatoform, addictive, and other forms
of specific disorders.However,since point estimates for
depression and anxiety disorders alone are well above
10%,and on the basis of community surveys,well-estab-
lished patterns of comorbidity,and crude estimates from
studies that used diagnostically unspecific caseness ques-
tionnaires and rating scales, we can speculate that the
overall prevalence of any mental disorder is about 30%.
This estimate should be regarded as conservative,
because only anxiety, depressive, substance abuse,
somatoform,and sleep disorders are taken into account.
The broad variation between currently available estimates
signals that there is need for further descriptive epidemi-
ological studies.In order to advance our general under-
standing and assist in the planning of improved care in pri-
mary care settings,such descriptive studies should ideally
be multinational to reflect cultural and regional differences
in help-seeking and system characteristics.They need to
take into account: (i) a fuller range of mental disorders
than previous studies;(ii) a greater detail in describing pat-
terns of comorbidity,both within the spectrum of mental
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Figure 2. Consecutive primary care attendees with nicotine dependence:
recognition and management by primary care physicians.
Recognized
no further
need for
intervention
33%
Advice to
quit only
40%
Actual attempt
at treatment
for cessation
3%
Not
recognized
24%
Nicotine-dependent smokers in primary care (n=3992)
Prevalence males: 16%
Prevalence females: 12%disorders as well as associations with somatic disorders;
(iii) measures of severity and pattern,as well as disability;
and (iv) some assessment of met and unmet needs for
intervention from patients’ and doctors’ perspectives.We
know that mental disorders—like somatic disorders (eg,
diabetes,hypertension,retinopathy,and cardiovascular dis-
ease
55)—are usually comorbid with each other,and that
these patterns of comorbidity have dramatic effects on
treatment,prognosis,course,and outcome.Diagnostically
comprehensive studies are therefore of high priority.The
fact that the establishment of mental disorders alone can-
not always be equated simply with the need for a specific
treatment,the additional coverage of severity,disability,
and subjective need for care measures is another core ele-
ment of improved further studies. Undoubtedly, there
might still be some need for studying previously neglected
single disorders,especially those for which effective treat-
ment has been established.However,given the time bur-
den of GPs and the numbers of patients with mental dis-
orders,the search for clinically meaningful typologies of
patients according to their profile of mental disorders
might be the most important target for the future.This is
particularly true if we consider that it is unlikely that sim-
plified classifications of mental disorders for use in primary
care will become available in the immediate future.
Recognition
If unselected patients are diagnosed independently,
using appropriate diagnostic instruments for a given
mental disorder, almost all studies—irrespective of the
type of diagnosis considered—come to the same con-
clusion:mental disorders are largely underrecognized in
primary care.GPs fail to recognize mental disorders,par-
ticularly when the task is to make a specific diagnosis,
whereas the more unspecific task of determining
whether a given patient has at least some form of men-
tal disorder (“mental health caseness”) seems to be
somehow better.Although improvement in diagnosis
has been the target of countless campaigns over the past
two decades on all levels (patients,doctors,and the pub-
lic),for example,in depressive disorders,improved rates
of caseness and diagnostic recognition are rare or at best
quite moderate.The upper limit of the correct recogni-
tion of depressive disorders is at most somewhere
between 50% and 70%, if threshold major depressive
disorders or nicotine dependence are considered. For
diagnoses that have received less attention, such as
GAD, eating disorders, substance abuse disorders, and
somatoform disorders, recognition rates are usually in
the range of 30% to 50%. Crude comparisons over the
past two decades in regions with campaigns to improve
recognition have revealed some,albeit moderate,effect.
However,some studies have also pointed out that using
recognition rates as a measure of the quality of doctors’
diagnostic decisions might be misleading and suggested
that it is inappropriate to assume that patients will have a
better outcome if they are diagnosed and treated. As
noted and discussed recently by Goldberg
56 and Höfler
and Wittchen,
57 higher recognition rates might occur at the
expense of doctors’ oversensitivity and increased willing-
ness to diagnose mental disorders at the expense of speci-
ficity.Obviously,many patients who clearly fail to meet
criteria for depression according to the ICD-10 or the
DSM-IV receive a diagnosis of depression by the doctors.
The ongoing controversies of lowering the criteria thresh-
olds for MD and/or defining new forms of subthreshold
depressive disorders (brief recurrent depression,mixed
anxiety/depression,etc) could have added to this prob-
lem.However,this tendency toward increased willingness
to assign depression diagnoses is not without danger.As
noted by Höfler and Wittchen,
57 it remains open, for
example,whether established treatments for MD are as
effective in these subthreshold manifestations.More dis-
turbing, however, is the fact that, despite doctors’
increased willingness to diagnose some form of depres-
sion,most patients with clear MD remain undetected and
untreated.
This raises two important questions.After considerable
efforts at improvement,are the current recognition rates
of mental disorders are really poorer than recognition
of somatic disorders? Do different factors account for
nondetection in mental as opposed to somatic disorders?
In the eighties,researchers in hypertension used the rule
of halves to describe the fairly consistent finding that
only half of all hypertensive patients are recognized,and
only half of those correctly recognized receive treat-
ment.This observation has prompted countless clinical
and political campaigns and considerable action to
improve the quality of care in hypertension.Yet the out-
come of 20 years of action in this field has recently been
described as disappointing,with no considerable change
in primary care.
58 Comparing this with depression—a
disorder that has seen a similar degree of attention in
this time period—suggests that screening,awareness,and
recognition studies on depression in primary care world-
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find that only slightly more than 50% of primary care
patients with depression are diagnosed correctly by their
GP—a finding that resembles that from hypertension
research.
The failure of attempts to improve physicians’ detection
skills has usually been attributed to the fact that most
awareness programs—as well as the numerous and heav-
ily campaigned treatment guidelines and programs—have
no large and,more importantly,no sustained effect on the
primary care physicians’ routine behavior. It is not
entirely clear why this is the case or to what degree spe-
cific diagnostic effects play an essential role.As is the case
for hypertension,patients with mental disorders are bet-
ter recognized when they have a more severe disorder or
have been diagnosed or even treated previously,or when
they present with core symptoms or clearly associated
complications. The core barrier for both mental and
somatic disorders is the same: if the patient does not
specifically and spontaneously report at least some of
those key complaints that give a hint at the diagnosis,the
doctor will have few reasons to specifically ask or even
screen for this. Some authors have suggested that poor
recognition of anxiety and depression is primarily and
specifically due to the fact that patients with psychologi-
cal disorders somatize,ie,they present with common—
though misleading—somatic symptoms instead of clear-
cut mood or anxiety symptoms.Others argued that poor
recognition is merely the result of thresholds, meaning
that if the depression is severe enough it will be recog-
nized.Both explanations have recently been called into
question.The somatization hypotheses do not appear to
be specific to mental disorders, because comparable
processes also apply to a wide range of somatic disorders
(hypertension, cardiac disorders, and diabetes
58) not
acutely linked to specific patient complaints.The severity
or threshold hypothesis
56 has been called into question
because severity was shown to have no significant effect
when one controls for comorbidity and past history in
multiple regressions.Thus,there are few indications that
poor diagnostic recognition of mental disorders is a
unique and specific phenomenon,rather poor diagnostic
recognition in primary care seems to be strongly influ-
enced by general factors (see below).Further,it should be
noted that there are few reasons to believe that psychia-
trists and psychotherapists would generally reveal a con-
siderable better profile of diagnostic recognition,if the
same rigid criteria were applied.However,such studies
have not yet been conducted with a similar degree of
detail in the mental health specialty sector to provide evi-
dence for this claim.
Intervention and treatment
Another question is whether the low recognition rates
for mental disorders really matter.An assumption in pri-
mary care research on recognition and appropriate
treatment is that once patients are recognized correctly
their chances of getting appropriate treatment increase,
and thus their course and outcome will be more favor-
able.There is some evidence in depression and anxiety
research supporting this.
30,34 If, for example, patients are
recognized as having “definite” MD, they are at least
three times more likely to receive state-of-the-art treat-
ment. Further evidence indicated that if the patient is
only recognized as “probable depression”or simply as a
“case with a mental disorder,”then doctors’ subsequent
choice of type and duration of treatment is considerably
worse than for patients with a definite depression diag-
nosis.This clearly signals that diagnostic certainty and
precision matters. It may be insufficient—or even dan-
gerous—to simply rely on diagnostically unspecific case-
ness decisions in treating patients as suggested by
Goldberg,
56 given the existence of various treatment and
management guidelines.
Yet the evidence that improved recognition results in
more favorable outcome for the patient is scarce and
partly controversial.
21,59,60The failure to demonstrate bet-
ter outcomes as a result of improved recognition rates
and treatment programs, however, could simply reflect
the inappropriateness of our illness and diagnostic mod-
els,or could be the result of suboptimal designs.It could
also reflect a more general core problem: namely that
our current treatment methods might not work that well
in primary care conditions.
Within our medical models, we assume that treatment
demonstrated as effective in randomized clinical trials
(efficacy) will also work in primary care (effectiveness).
This assumption neglects a considerable number of
problems in primary care: patients in primary care
might be different from those sampled rigidly with
many inclusion and exclusion criteria in randomized
clinical trials in specialized settings; doctors might not
be able to practice the intervention with the same treat-
ment integrity as specialists; treatment in primary care
operates under much more restrictive conditions than
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tion; and the length of treatment components may be
shorter than in trials. The marked lack of systematic
research does not allow determination of which of these
factors is the most critical.
Another neglected question beyond the recognition issue
is which type of mental disorder can appropriately be
managed in primary care and which disorders must be
treated elsewhere. During the past two decades, quite
comprehensive,interdisciplinary,mental health system
providers have emerged in most industrialized countries
to ensure enhanced availability and improved continuity
of appropriate treatment component through the illness
process.At the same time (unlike in the seventies), an
ever-increasing number of effective medications and psy-
chological treatments have become available,which have
been shown to be effective in all types of acute depres-
sive disorders, as well as in prevention of further
episodes.Numerous national and international manage-
ment guidelines and allocation rules,based on consensus
meetings for more complex combined drug–psycho-
therapy interventions,have been developed that go far
beyond the simple and naive counseling practice fre-
quently applied in clinical routine.However,the avail-
able evidence suggests that these more or less complex
networks,and their current level of coordination,do not
sufficiently match the needs of depressed patients or,
indeed,experts’ expectations.The existing complexity of
various treatments and patient management strategies
developed by experts in research settings has to be more
appropriately translated into clinical reality,be it in pri-
mary care or specialist settings with medical, social, or
psychological focus, in order to both improve the
patients’ acute suffering and manage them through to
long-term recovery and improve their quality of life more
efficiently.Partial response,incomplete remission,as well
as overlooked and persisting comorbid vulnerabilities
have all been demonstrated to be unfavorable long-term
predictors.
Structural issues and policy in the primary care man-
agement of mental disorders
To conclude,because of the many problems with the pri-
mary care management of mental disorders, it is likely
that there is no single solution. Rather, we need to
address multiple solutions aimed at various levels and
parts of the system simultaneously and consistently.
61
Patient education
Since many of the problems involve lack of understand-
ing (and considerable misunderstanding or stigma) of
mental disorders and specific diagnoses,at least some con-
tinuous and significant efforts must aim toward commu-
nity and patient education.As the general public,patients,
families,and potential patients of all age groups become
better informed about specific mental disorders and their
treatments, they are more likely to present with “real”
problems and seek treatment,and to demand for specific
treatment.Such pressures will certainly have some impact
on the willingness of GPs to change their behavior.
Training primary care providers
Since it is undisputable that many primary care providers
have only minimal training in the detection,treatment,
and referral mechanisms of mental disorders,educational
programs remain important in both training and practice.
Such programs can at least keep providers up to date with
new diagnoses,treatments,and management strategies.
While other factors (time,motivation) may be important
for the actual implementation,at least a very basic under-
standing is provided.What remains unresolved here is by
what mechanisms such programs are most successfully
implemented.Clearly,the endless production of guide-
lines is insufficient,as are continuing education programs
and visits by representatives of pharmaceutical compa-
nies.Rather,we need to search for the most appropriate
dissemination and translation strategies in primary care
settings.More systematic research is needed to identify
factors related to formats and physicians, as well those
related to organizations and financial considerations asso-
ciated with successful implementation.
Clinical practice
Primary care physicians’ work is subject to considerable
time restrictions,in terms of the number of patients (up to
60 patients a day in some countries),the broad spectrum
of all medical conditions and presenting symptoms,and
the high point-prevalence of variable expressions of
depressive disorders (about 10% including all types,sever-
ity, and patterns of comorbidity).
7,15-19 As managed care
predominates,expectations are increasing.Particularly in
countries with an extremely high average numbers of
patients (over 60 patients a day in Germany),the reduc-
Mental disorders in primary care - Wittchen et al Dialogues in Clinical Neuroscience - Vol 5 . No.2 . 2003
125tion in time per patient to only a few minutes on a typical
day probably forms a severe obstacle to improvement of
both recognition and intervention,may it be treatment or
referral.While screening tools might be partly successful
in countries where GPs have at least 10 to 15 min per
patient,they are clearly of little use in countries where GPs
have less than 10 min with their patients.
This obstacle can only be overcome by structural changes
in the organization and reimbursement schemes,because,
even if simple and efficient screening tools are used, a
proper differential diagnostic workup is unlikely given the
GPs’ short period of time per patient.The time pressure
in everyday practice is also responsible for difficulties in
successful referral to mental health specialists and other
more efficient interventions.
19Among models for this,the
so-called collaborative model is the most popular.In this
approach,nurses,psychologists,and social workers (pri-
mary care team) work together within the primary care
setting as facilitators taking over some of the burdensome
tasks of screening,monitoring,counseling,and patient edu-
cation.
61,62 Other approaches proposed the development of
disease management programs for specific types of mental
disorders,similar to those existing in diabetes and other
chronic conditions.More critical propositions,that target
explicitly the cost component,have been the implementa-
tion of pharmacy benefit manager.In this model,pharma-
cists review GPs’ prescriptions with regard to drug,dosage,
drug interactions, duration, and cost, and make recom-
mendations to the GP and the patient (compliance and
adjunctive treatment). Although this model has some
attractiveness for policy makers, this approach has also
negative effects in terms of invasion of privacy and inter-
ference with physicians’ treatment decisions.
Research context
In order to set the context for exploring explanations for
the gap between what is potentially achievable and what
actually exists in primary care, there is a need for sys-
tematic stepwise inquiry in four domains:efficacy,effec-
tiveness,practice research,and service systems research.
As efficacy studies most frequently serve for approval of
medications,the gold standard remains randomized clin-
ical trials, with strict highly controlled inclusion and
exclusion criteria,and mostly one or two symptom out-
come measures of 8 weeks or a few weeks longer.
Because primary care patients are often highly comorbid
and rarely allow sufficient adherence to such strict pro-
tocols,few efficacy studies on mental health treatments
are currently being conducted in primary care settings
and,when they are,highly trained specialist components
are usually embedded, which means that they do not
reflect the typical primary care situation.These limita-
tions call for greater emphasis on effectiveness research,
which aims to establish whether an intervention has a
measurable effect in broader populations and real ser-
vice settings; inclusion and exclusion criteria are more
relaxed,and clinicians can be less specifically trained in
the research methods.The important benefit of this type
of research is the expansion of outcome measures, for
example,with regard to functional status,quality of life,
use of health services,and costs.Because of the interest
in expanding the generalization of treatments and inter-
ventions,there have been a gradually increasing number
of such primary care studies,for example,in depression,
suggesting that these studies are feasible in primary care,
and that findings similar to those in efficacy studies can
be obtained.However,one needs to acknowledge that
the findings may be less robust,due to the influence of a
higher variability of both patient and physician factors.
In addition,explicit practice and service system research,
a term that largely overlaps with quality of care evalua-
tion studies (allocation studies,dissemination research),
can additionally help identify those factors that affect
choice,implementation,and delivery of treatments and
services,as well as patient,provider,organizational,and
cost factors,which have an impact on quality of care and
outcomes of mental health treatments. ❏
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